. Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells. Am. J. Physiol. 274 (Renal Physiol. 43): F473-F480, 1998.-Arginase shares a common substrate, L-arginine, with nitric oxide synthase (NOS). Both enzymes are active at inflammatory sites. To understand regulation of arginase and its relationship to nitric oxide (NO) production, we studied effects of N G -hydroxy-L-arginine (HOArg) and interleukin-4 (IL-4) on urea and NO 2 Ϫ synthesis by glomeruli during rat immune glomerulonephritis and compared these with macrophages and glomerular mesangial cells (MC). In nephritic glomeruli, elicited macrophages, and MC stimulated with IL-1 and adenosine 3Ј,5Ј-cyclic monophosphate agonists, increased arginase and induced NOS activity was found. Urea production was inhibited by HOArg and increased by IL-4. NO inhibition [N G -monomethyl-L-arginine (L-NMMA)] increased arginase activity in nephritic glomeruli and macrophages but not MC. NO 2 Ϫ synthesis was inhibited by L-NMMA and IL-4. It was increased with HOArg under conditions of NO inhibition. In contrast, in normal glomeruli and basal MC, where there was no induced NO synthesis, IL-4 had no effect on arginase activity, whereas HOArg consistently reduced it in glomeruli only. Type II arginase (Arg II) mRNA was detected in normal glomeruli; nephritic glomeruli expressed both Arg I and Arg II mRNAs. This is the first demonstration of arginase modulation in glomeruli and MC and of the expression of arginase isoforms in glomeruli. The differential responses to two endogenous compounds generated by inflammation suggest this may be part of coordinated regulation of arginase and inducible NOS in immune injury, whereby arginase is inhibited during highoutput NO production and stimulated with NO suppression. This, together with control of arginase and NOS isoforms, may be important in controlling the balance of inflammatory and repair mechanisms.
ARGINASE CATALYZES the conversion of L-arginine to L-ornithine and urea. Arginase activity is found in many tissues that do not express a complete urea cycle (26, 31) . The function of this type of arginase is unknown, but potential roles in inflammation and immunity are likely, as high activity is found in stimulated macrophages (20) and inflammatory lesions (1, 21) . As arginase and nitric oxide synthase (NOS) share a common substrate, the regulation of arginase is linked with nitric oxide (NO) production, and it has been suggested that the balance of L-arginine metabolism between these two pathways has important pathophysiological effects (2, 36) . The regulation of L-arginine metabolism in tissues that possess both arginase and NOS activities is poorly understood. Enhanced arginase products have been shown under conditions of NO inhibition (16) , implicating substrate competition between the arginase and NOS enzymes as one mechanism of control.
Several endogenous compounds already implicated as chemical mediators in inflammatory reactions have been shown to modulate arginase activity (3, 39) . Most of these compounds also affect NO production. Recently, an intermediate in the conversion of L-arginine to NO and L-citrulline, N G -hydroxy-L-arginine (HOArg) (54) , has been shown to be a potent inhibitor of purified rat liver arginase (5, 22) and of the arginase activity found in macrophages (5, 24, 27) , endothelial cells (8) , gastric mucosal cells (9) , and the insulinoma cell line, RINm5F (19) . This compound is increased in the serum of endotoxin-treated rats (25) and is present in the serum of healthy humans (35) . Conversely, two Th2 lymphocyte-associated cytokines [interleukin-1 and -10 (IL-4 and IL-10, respectively)] have been shown to increase arginase activity (18, 36) .
Immune-mediated glomerulonephritis is an inflammatory reaction characterized by induced NOS and arginase activity in nephritic glomeruli (10, 29, 32) . Both macrophages and intrinsic glomerular mesangial cells possess arginase and inducible NOS (iNOS) activity and are possible sources in vivo. We have therefore examined the effects of potential modulators of arginase activity on nephritic glomeruli, on mesangial cells and macrophages, and on the isoforms of arginase in glomeruli, as a means of understanding further the regulation and role of arginase in glomerulonephritis and its relationship to NOS.
MATERIALS AND METHODS

Animals and Chemicals
Inbred male Lewis rats bred at Imperial College School of Medicine at St Mary's were used for all experiments. All reagents were obtained from Sigma-Aldrich (Dorset, UK), unless otherwise stated.
Macrophages
Thioglycollate-elicited peritoneal macrophages were cultured as previously described (29) . Cells were plated at 10 6 /ml in 16-mm plastic wells (Nunc, Roskilde, Denmark) in 1 ml Dulbecco's modified Eagle's medium (DMEM), supplemented with 4 mM L-glutamine, 1 mg/ml bovine serum albumin (BSA), 100 U/ml penicillin, and 100 µg/ml streptomycin.
Mesangial Cells
Mesangial cells were isolated, cultured, and characterized, as previously described (10, 16) . Cells were used between passages 7 and 16 in four separate experiments. The results shown here are from one representative experiment. Confluent cultures were incubated in 22-mm plastic wells in 0.5 ml RPMI 1640 supplemented with 1 mg/ml BSA, 100 U/ml penicillin, and 100 µg/ml streptomycin. Mesangial cell protein was measured by the microbicinchoninic acid assay.
Glomerulonephritis
Accelerated nephrotoxic nephritis was induced by preimmunization with rabbit immunoglobulin G (IgG) in Freund's complete adjuvant, followed after 7 days by intravenous rabbit anti-rat glomerular basement membrane (GBM) globulin, as previously described (10) . Rats were killed at 4 and 7 days after anti-rat GBM globulin.
Glomeruli were isolated from kidneys by differential sieving (14) and cultured in 16-mm plastic wells at 2,000/ml in 1 ml DMEM supplemented with 4 mM L-glutamine, 1 mg/ml BSA, 100 U/ml penicillin, and 100 µg/ml streptomycin.
Arginase Activity and NO 2 Ϫ Synthesis
Glomeruli and cells were incubated for 48 h at 37°C. L-[guanido-14 C]arginine (2.1 Gbq/mmol, NEN-DuPont UK, Nottingham, UK) was added to the media to provide Ϸ10,000 counts · min Ϫ1 ·ml Ϫ1 (final concentration, 0.25 µM). They were cultured in the absence and presence of N G -monomethyl-Larginine (L-NMMA, 300 µM; Cyclops Biochemical), HOArg (2-200 µM, Calbiochem-Novabiochem), IL-1␤ (2 nM; NIBSC, Potters Bar, UK), 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM), cholera toxin (1 µg/ml), and IL-4 (8-800 ng/ml). Recombinant rat IL-4 was produced as a cell culture supernatant from Chinese hamster ovary (CHO)-K1 cell line transfected with rat IL-4 cDNA (a gift from Dr. D. Fowell, Medical Research Council Immunology Unit, Oxford, UK) (34) . The specific activity of recombinant rat IL-4 was 2,000 units/µg (assessed by upregulation of activity of MHC class II molecule expression in splenic B lymphocytes) (46) . The endotoxin level was 60 pg/ml in the cell culture supernatant, as assessed by Limulus amoebocyte lysate assay (lower limit of detection, 50 pg/ml), using a test kit (Kabi Vitrim, Uxbridge, UK). Cell culture supernatant from the parent CHO-K1 cell line (endotoxin level, Ͻ50 pg/ml) was used as a negative control.
Arginase activity was measured in cultures by assaying the production of [ 14 C]urea from L-[guanido-14 C]arginine in culture supernatants (extracellular arginase activity), as previously described (29, 49) . NO 2 Ϫ in culture supernatants from the same wells was measured by the Griess reaction (10) .
Intracellular arginase was assayed by radiometric assay performed on cell lysates (29, 48) .
Reverse Transcription-Polymerase Chain Reaction
RNA isolation and reverse transcription-polymerase chain reaction (RT-PCR) were performed on nephritic glomeruli (day 4, accelerated nephrotoxic nephritis) and normal glomeruli, as described previously (15) . The PCR primers for type I arginase (Arg I) were those used by Buga et al. (8) . The primers for type II arginase (Arg II) were designed using the sequence submitted by Iyer and Grody (accession no. U-90887 NID). Arg II primers, which amplify a product of predicted length 612 bp, are 5Ј GCT-GTG-TCA-CAC-TGG-GAG-GAG-ACC 3Ј and 5Ј CTG-CTA-GGC-TGG-CTG-TAG-CCT-TGG 3Ј. PCR was carried out with an annealing temperature of 58°C for 35 cycles, using two dilutions for each sample, corresponding to 10 and 100 ng of RNA per reaction. The identity of the 612-bp reaction product was confirmed by cleavage into predicted fragment sizes of 142 and 470 bp by the restriction enzyme Dsa I.
Statistics
Data are presented as means Ϯ SE for triplicate wells. Analysis of variance with Fisher's protected least significant difference and Student's t-tests was used.
RESULTS
Effect of HOArg and IL-4 on Peritoneal Macrophages
These compounds had dose-dependent effects on arginase activity (Fig. 1A) . HOArg caused greatest inhibition at 200 µM; IL-4 increased activity maximally at 80 ng/ml. In view of these results, the concentrations used in experiments on mesangial cells and glomeruli were 200 µM HOArg and 80 ng/ml IL-4, respectively. HOArg did not change NO 2 Ϫ production, but IL-4 decreased NO 2 Ϫ production by ϳ30% at all concentrations. Control CHO cell media did not affect arginase activity or NO 2 Ϫ production in macrophage, glomerular, or mesangial cell experiments.
To examine interaction with the NOS pathway, these experiments were repeated in the presence of the NOS inhibitor L-NMMA (Fig. 1B) . L-NMMA reduced basal NO 2 Ϫ generation by 89% and caused a 3.7-fold increase Ϫ generation to a similar degree at all concentrations (8-800 ng/ml, P Ͻ 0.05, compared with no IL-4) (Fig. 2) .
Effect of HOArg and IL-4 on Unstimulated Mesangial Cells
Arginase activity was variably affected by HOArg (there was a significant reduction in only 1 of 4 experiments) and unaffected by IL-4 ( Fig. 3A) . Small but significant amounts of NO 2 Ϫ were produced from unstimulated cells in the presence of HOArg (Table 1) (P Ͻ 0.05); this NO 2 Ϫ was not inhibited by L-NMMA. Under basal conditions and with IL-4, NO 2 Ϫ concentrations were below the limit of detection.
Effect of HOArg and IL-4 on Stimulated Mesangial Cells
Stimulation with IL-1. IL-1 increased arginase activity by 60%, compared with unstimulated cells (P Ͻ 0.05) (Fig. 3B ). HOArg had no significant effect; however, IL-4 blunted the stimulatory effect of IL-1 (P Ͻ 0.05 vs. no IL-1). IL-1 induced NO 2 Ϫ production ( Table 1 ) (P Ͻ 0.01). HOArg caused a small but significant drop in NO 2 Ϫ production (P Ͻ 0.01), and IL-4 almost abolished NO 2 Ϫ production (P Ͻ 0.01). Stimulation with adenosine 3Ј,5Ј-cyclic monophosphate agonists cholera toxin and IBMX. Adenosine 3Ј,5Ј-cyclic monophosphate (cAMP) agonists increased arginase activity by 79%, compared with unstimulated cells (P Ͻ 0.01) (Fig. 3C) . HOArg had no effect, whereas IL-4 augmented this activity by an additional 38% (P Ͻ 0.01). cAMP agonists alone did not induce NO 2 Ϫ production. HOArg caused a small but significant increase in NO 2 Ϫ (P Ͻ 0.05); IL-4 had no effect (Table 1) . Stimulation with IL-1 and cAMP agonists. cAMP agonists in combination with IL-1 were used to stimulate maximal NO 2 Ϫ production. This doubled arginase activity, compared with unstimulated cells (P Ͻ 0.01) (Fig. 3D) . HOArg significantly inhibited (P Ͻ 0.01) and IL-4 increased arginase activity (P Ͻ 0.05). This combination stimulated greater NO 2 Ϫ production than IL-1 alone (P Ͻ 0.01). HOArg slightly inhibited (P Ͻ 0.05) and IL-4 strongly inhibited NO 2 Ϫ production (P Ͻ 0.01) ( Table 1) .
NO inhibition with L-NMMA did not alter arginase activity in either unstimulated or stimulated mesangial cells (data not shown).
Effect of IL-4 on intracellular arginase activity in mesangial cells. Mesangial cells were incubated with or without the combination of IL-1␤ and cAMP agonists in the presence or absence of IL-4. IL-4 caused a 21% increase in intracellular arginase activity (stimulated cells ϩ IL-4 vs. basal, P Ͻ 0.05; IL-4 increased arginase activity in basal cells but this did not reach statistical significance).
Effect of HOArg and IL-4 on Glomeruli
Preimmunization with subsequent administration of anti-GBM globulin induced a proliferative glomerulonephritis with macrophage infiltration. As we previously reported (29) , there was arginase activity in normal glomeruli, which was significantly increased in ne- http://ajprenal.physiology.org/ phritic glomeruli at day 4 (P Ͻ 0.05) (Fig. 4) . HOArg inhibited arginase activity in both normal and nephritic glomeruli (Fig. 4A) . In contrast, IL-4 significantly increased the activity but only in nephritic glomeruli. Nephritic, but not normal, glomeruli generated significant NO 2 Ϫ ( Table 2 ) (P Ͻ 0.01). This was markedly reduced by IL-4 (P Ͻ 0.05); HOArg had no effect. In normal glomeruli, NO 2 Ϫ was higher in the presence of HOArg (P Ͻ 0.05).
NOS inhibition with L-NMMA did not alter arginase activity in normal glomeruli (Fig. 4B) . In nephritic glomeruli under basal conditions and with HOArg, L-NMMA increased arginase activity (P Ͻ 0.05, basal and with HOArg). The IL-4-enhanced arginase activity was no greater in the presence of L-NMMA. L-NMMA inhibited NO 2 Ϫ generation by nephritic glomeruli under basal conditions (P Ͻ 0.01), with HOArg (P Ͻ 0.01) and with IL-4 (P Ͻ 0.05) ( Table 2) .
The responses to IL-4, HOArg, and L-NMMA were identical in day 7 glomeruli (results not shown).
Expression of Arginase Isoforms Arg I and II in Glomeruli
Arg II was detected in both normal and nephritic glomeruli; Arg I was only detected in nephritic glomeruli (Fig. 5) .
DISCUSSION
We have previously reported that nephritic glomeruli show activity in two major pathways of L-arginine metabolism, iNOS-dependent NO production (10-12, 17) and urea and ornithine synthesis via arginase (29) . The role of arginine metabolites in glomerulonephritis is unknown. NO could promote injury through its cytotoxic effects, modulate glomerular hemodynamics, or have anti-inflammatory effects by inhibiting leukocyte migration and neutralization of other reactive radical species (13) . It has been suggested that arginase and its products at inflammatory sites produce an environment favorable for healing fibroblast replication and collagen synthesis (51) . To understand the significance of arginase activity in immune inflammation and its interaction with NO synthesis, we have now examined the effects of two compounds, HOArg and IL-4, endogenous compounds increased in vivo in inflammation (25, 30, 41) and recently shown to modulate arginase activity (5, 8, 9, 18, 19, 22, 24, 27, 36) . HOArg is an intermediate in the conversion of L-arginine to NO; it accumulates in the culture medium of cells synthesizing NO (8) . IL-4 is a lymphocyte-derived cytokine synthesized mainly by Th2 cells; it has been reported to increase arginase activity in macrophages (18, 36) and also inhibits macrophage iNOS expression (33, 42) . We measured arginase activity by measuring the synthesis of urea from L-arginine in culture and NOS activity by measuring NO 2 Ϫ synthesis. The assay of these end products will detect changes in the amounts of the respective enzymes, changes in their activity due to the presence of inhibitors, or changes in the quantity of L-arginine substrate available to the enzyme.
HOArg and IL-4 modulated glomerular arginase activity and NO 2 Ϫ production. HOArg inhibited arginase activity in both normal and nephritic glo- http://ajprenal.physiology.org/ meruli, and IL-4 enhanced the activity in nephritic glomeruli. This action of IL-4 could be highly relevant in vivo, for it has recently been detected in nephritic glomeruli (30, 41) . Whether there is significant production of HOArg in glomeruli is unknown. NO inhibition increased basal arginase activity in nephritic glomeruli, as we have previously reported (16) . One explanation for this effect is competition between the two pathways for substrate and reduction of NO synthesis, allowing more L-arginine to enter the arginase pathway. The Michaelis constant (K m ) for arginine as a substrate for macrophage arginase is relatively high (4-9 mM) (7), consistent with this. Alternatively, when NOS is active, HOArg, produced as an intermediate, inhibits arginase activity, and this inhibition is reduced when the NOS pathway is blocked by L-NMMA. HOArg and IL-4 were still able to modulate arginase activity when NO synthesis was inhibited by L-NMMA, showing that the stimulatory effect of IL-4 on arginase activity is not simply due to inhibition of NO synthesis. The glomerular nitrite synthesis in nephritic glomeruli was inhibited by IL-4. Normal glomeruli do not produce nitrite ex vivo; addition of HOArg led to detectable levels of nitrite, not inhibitable by L-NMMA. This suggests that HOArg is either able to enter the synthetic pathway downstream of the point where L-NMMA exerts its inhibitory effect on NOS or that there is an alternative pathway by which HOArg is converted to NO 2 Ϫ , possibly catalyzed by P-450, as suggested by other studies (6, 47) .
We then examined whether macrophages and mesangial cells, two cell types central to the inflammatory reaction in acute glomerulonephritis, behaved in the same way as nephritic glomeruli or whether differences in responses might reveal a dominant source of arginase in glomerulonephritis. Arginase modulation has previously been studied in several macrophage cell types, but this is the first report examining the mesangial cell, an intrinsic glomerular cell closely related to vascular smooth muscle. In both cell types, HOArg and IL-4 modulated arginase activity. In macrophages, HOArg reduced and IL-4 increased arginase activity, consistent with previous reports for alveolar (24) and bone marrow-derived (18, 36) macrophages. NO inhibition increased arginase activity, as we (16) 
Ϫ synthesis, consistent with previous reports that it reduces iNOS activity in stimulated macrophages (4, 33, 42) . When NO 2 Ϫ synthesis was inhibited by L-NMMA, addition of HOArg increased nitrite as seen with glomeruli.
In glomeruli and cultured mesangial cells, there is constitutive arginase activity, as we have previously reported (29) . When glomeruli are stimulated by immune complex injury or mesangial cells by IL-1 or cAMP agonists, we find there is a significant increase in arginase activity. This suggests that, in vivo, under conditions of cytokine or other inflammatory stimulation, intrinsic glomerular mesangial cells could be a major source of L-ornithine synthesis. IL-4 further enhanced the arginase activity of mesangial cells stimulated with IL-1 and cAMP agonists, and this was due to increased intracellular arginase. IL-4 did not affect the arginase activity of unstimulated mesangial cells. This may explain why IL-4 did not affect the arginase activity of normal glomeruli but enhanced it in nephritic glomeruli. IL-4 reduced IL-1-stimulated arginase activity (37) . As IL-4 inhibits IL-1-induced prostaglandin E 2 (PGE 2 ) synthesis in mesangial cells and PGE 2 stimulates arginase activity in macrophages (18) , this effect could be through loss of PGE 2 . An inhibitory effect of IL-4 on IL-1-stimulated mesangial cell collagen synthesis has also been reported (38) . We were unable to show a consistent inhibitory effect of HOArg on basal arginase activity in mesangial cells. This could indicate that the basal expression is from a form of arginase less susceptible to HOArg inhibition or may be because HOArg is not efficiently transported into resting mesangial cells.
Two distinct and nonhomologous arginase genes exist in mammals, and their products have been termed arginase I and arginase II (53) . Arginase I is found predominantly in the liver but is also induced in rat peritoneal macrophages, in response to lipopolysaccharide (LPS) stimulation (52) . Arginase II is present in extrahepatic tissues, including kidney, small intestine, and lactating mammary gland. The gene for arginase II has recently been cloned in humans (56) and rats (23) . This isoform may also be induced by appropriate stimuli. Fig. 5 . Expression of arginase isoforms type I (Arg I) and type II (Arg II) in normal and nephritic glomeruli. Two dilutions of template (10 and 100 ng total RNA) were used from two normal and two nephritic rats in polymerase chain reaction.
F477 MODULATION OF ARGINASE IN GLOMERULI
In a murine macrophage cell line, LPS stimulation led to increased arginase activity, and immunoprecipitation experiments showed that this was due to an increase in arginase II levels (57) . In the same cells, cAMP agonists have been shown to increase levels of mRNA for arginase II (23) . Similarly, in rat aortic endothelial cells, there was constitutive expression of arginase I and induction of arginase II by LPS (8) . We have now examined the expression of the mRNA for these two isoforms in normal and inflamed glomeruli. We found that, in normal glomeruli, only arginase II was detectable, whereas, in nephritic glomeruli, both isoforms were expressed. These are the first studies showing differential expression of arginase isoforms at an inflammatory site. Our results indicate that, in normal glomeruli, there is constitutive expression of arginase II by an intrinsic glomerular cell, most likely the mesangial cell. The expression of arginase I during nephritis may either reflect induction in intrinsic glomerular cells or an influx of activated macrophages expressing this isoform.
Glomerular mesangial cells synthesize NO via the high-output iNOS enzyme (44) . NO 2 Ϫ synthesis induced in mesangial cells by IL-1, or IL-1 and cAMP agonists was markedly inhibited by IL-4, as has been previously shown in macrophages (4) and human mesangial cells (50) . This is the first demonstration of a similar inhibitory effect in rat mesangial cells. Other cytokines, such as transforming growth factor-␤ (TGF-␤), plateletderived growth factor (PDGF), and IL-13, have been shown to reduce mesangial cell NO synthesis (43, 45, 50) . Unlike macrophages and nephritic glomeruli, inhibition of mesangial cell NO synthesis had no effect on arginase activity, even with the high NO 2 Ϫ levels synthesized by IL-1-and cAMP agonist-stimulated cells. One possible explanation is compartmentalization of arginase and NO synthesis in mesangial cells; another is that the cultures of mesangial cells are heterogeneous, with some cells synthesizing NO and others synthesizing arginase. Recent data have shown that only a proportion of mesangial cells in culture can be stimulated to synthesize iNOS (40) .
These experiments have not determined the source of arginase activity in nephritic glomeruli, since the response to HOArg and IL-4 were similar to nephritic glomeruli in both in vitro cell types. It is likely that both macrophages and mesangial cells contribute to arginase activity in the inflamed glomerulus, although, quantitatively, mesangial cells are likely to be the main source of the arginase activity measured in nephritic glomeruli (16) .
From these results, we suggest the following hypothesis for the activity of these pathways in the glomerulus in vivo. In the normal glomerulus, there is low basal arginase activity, due to the presence of arginase II in mesangial cells, but the iNOS pathway is inactive. The function of the arginase generated here may be to sustain normal protein synthesis for glomerular cells and extracellular matrix. In nephritic glomeruli, there is increased arginase activity, due to induction of arginase I and possibly also increased activity of arginase II. The relative activities of the two pathways of arginine metabolism will be modulated by inflammatory cytokines, the presence of inflammatory cells, the levels of available arginine, and accumulating HOArg. Our previous temporal analysis (16) showed high NO in the earliest phase of injury, followed, after several days, by increased arginase, and this pattern is also associated with wound healing (2) . The HOArg produced from the iNOS pathway may inhibit arginase, ensuring arginine availability for high-output NO production, as suggested by Buga et al. (8) . IL-4 is potentially a major mediator of the balance between the two pathways, since it is able both to inhibit iNOS activity in mesangial cells and macrophages and to stimulate arginase activity by enhancing the synthesis of arginase II. IL-4 mRNA and protein have been detected in glomeruli in experimental and human glomerulonephritis, and its administration has anti-inflammatory effects in acute glomerulonephritis (55) . Its effect on the pathways of L-arginine metabolism would be to reduce NO synthesis and promote the synthesis of urea and ornithine. Ornithine is able to act as a substrate for the synthesis of polyamines necessary for cell proliferation and proline needed for collagen synthesis. Thus IL-4 may play a major role in the switch from high NO during inflammation to low NO and increased ornithine synthesis during repair and regeneration.
These studies suggest that endogenous HOArg and IL-4 may be modulators of L-arginine metabolism in glomerular inflammation and important in controlling the balance of inflammatory and repair mechanisms. They also identify, for the first time, expression of arginase isoforms in the normal and nephritic glomerulus.
